Anupam Dalal serves as Executive at Aerpio Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Anupam Dalal has executed 7 insider transactions totaling $40.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 26, 2022 involved receiving (via award) 320,000 shares valued at $4.0M.
Anupam Dalal currently holds 1,849,402 shares of Aerpio Pharmaceuticals, Inc. (ARPO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anupam Dalal has been a net buyer of ARPO stock. They have purchased $40.0M and sold $0 worth of shares.
Anupam Dalal's most recent insider trade was on Sep 26, 2022, when they sold 320,000 shares at $12.50 per share.
Get notified when new Form 4 filings are submitted
| $13.08 |
| Discretionary |
| Aug 26, 2021 | AADI | $20.0M | Purchase | 1,529,402 | $13.08 | Discretionary |
| Jun 30, 2021 | ARPO | $11.2K | Award | 7,400 | $1.52 | Discretionary |
| Mar 31, 2021 | ARPO | $11.2K | Award | 7,290 | $1.54 | Discretionary |
| Dec 22, 2017 | ARPO | $0 | Other | 7,882 | $N/A | Discretionary |
| Dec 22, 2017 | ARPO | $0 | Other | 2,269 | $N/A | Discretionary |